Literature DB >> 6482317

[Cutaneous nodular Kaposi sarcoma following kidney transplantation and immunosuppression].

C Luderschmidt, G Hillebrand, L A Castro, C Hammer.   

Abstract

Five months after renal transplantation and an immunosuppressive trial with azathioprine and methylprednisolone, a black African female developed a cutaneo-nodular Kaposi's sarcoma that occurred symmetrically on the lower legs, thighs and forearms. Intensive search for visceral involvement was negative. Histologically, the nodes consisted of spindle cells; there were many new vessel formations with proliferation of atypical endothelial cells. After therapy with cytostatica and x-rays there was a time-limited disappearance of the Kaposi's sarcoma; 1 year later a relapse developed on the left lower leg. Field radiotherapy with accelerated electrons in a single dose of 8 Gy was successful. There is a greater incidence, in the literature, of Kaposi's sarcoma in immunosuppressed patients with organ transplants. Treatment with immunosuppressive substances is probably significant in the development of the Kaposi's sarcoma in those patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482317     DOI: 10.1007/bf01711854

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  KAPOSI'S SARCOMA. HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDIES.

Authors:  K HASHIMOTO; W F LEVER
Journal:  J Invest Dermatol       Date:  1964-12       Impact factor: 8.551

2.  Kaposi sarcoma in kidney transplant recipients.

Authors:  B D Myers; E Kessler; J Levi; A Pick; J B Rosenfeld; P Tikvah
Journal:  Arch Intern Med       Date:  1974-02

3.  Radiotherapy of Kaposi's sarcoma.

Authors:  M J Holecek; A R Harwood
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

Review 4.  Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus.

Authors:  D P Burkitt
Journal:  J Natl Cancer Inst       Date:  1969-01       Impact factor: 13.506

5.  Immunological studies in Kaposi's sarcoma in Uganda.

Authors:  S P Master; J F Taylor; S K Kyalwazi; J L Ziegler
Journal:  Br Med J       Date:  1970-03-07

6.  Kaposi's sarcoma and immunosuppressive therapy: an appraisal.

Authors:  R W Gange; E W Jones
Journal:  Clin Exp Dermatol       Date:  1978-06       Impact factor: 3.470

7.  De novo Kaposi's sarcoma in renal transplantation. Case report and brief review.

Authors:  M A Hardy; P Goldfarb; S Levine; A Dattner; F M Muggia; S Levitt; E Weinstein
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

8.  Disseminated Kaposi's sarcoma in homosexual men.

Authors:  A E Friedman-Kien; L J Laubenstein; P Rubinstein; E Buimovici-Klein; M Marmor; R Stahl; I Spigland; K S Kim; S Zolla-Pazner
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Immunosuppression in a homosexual man with Kaposi's sarcoma.

Authors:  E O Rasmussen; K D Cooper; K Kang; C R White; D H Regan; J M Hanifin
Journal:  J Am Acad Dermatol       Date:  1982-05       Impact factor: 11.527

10.  Delayed cutaneous hypersensitivity reactions in patients with Kaposi's sarcoma.

Authors:  J F Taylor; J L Ziegler
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.